onenucleus
Transformationunitgm
Covetrus Inc.
Grant Thornton UK LLP
Connect with headhunters to apply for similar jobsCSL Plasma Inc.
Scienceabode
Thepharmadaily LLP
Centre for Process Innovation Limited
Hilti Portugal
Thermo Fisher Scientific Inc.
A rapidly growing bioinformatics consultancy is seeking a consultant to support target identification and biomarker discovery. You will work on-site with clients, collaborating with experimental scientists to explore biological mechanisms and drive data-informed decisions. The role focuses on integrative analysis of molecular data in a dynamic R&D environment, requiring a strong foundation in bioinformatics and the ability to engage with cross-functional teams.
BioLizard (“The Lizards”) is a rapidly growing bioinformatics and data science consultancy that helps biotech and pharma organizations transform complex biological data into actionable insights. We combine deep biological expertise with state-of-the-art computational methods to accelerate drug discovery, biomarker development, and translational research.
As a BioLizard consultant, you’ll work on-site at our client’s premises, embedded as part of their bioinformatics team, supporting the discovery teams across different programs, to explore biological mechanisms and drive data-informed decisions in early R&D. You’ll collaborate closely with experimental scientists and computational peers to identify new targets, characterize models, and refine hypotheses that shape future therapies.
You will support target identification, validation, and biomarker discovery through integrative analysis of molecular data across systems and disease models. You’ll be part of a dynamic environment where curiosity, collaboration, and biological understanding meet data-driven rigor.
* The salary benchmark is based on the target salaries of market leaders in their relevant sectors. It is intended to serve as a guide to help Premium Members assess open positions and to help in salary negotiations. The salary benchmark is not provided directly by the company, which could be significantly higher or lower.